Dulaglutide vs. Semaglutide: What’s The Difference?

You may be wondering about the similarities and differences between these medications, especially if you’re deciding which ...
Healthline

Trulicity Injection Overview: Side Effects, Uses, Dosage, and More

Trulicity is a prescription drug used to help manage blood sugar levels and lower the risk of heart problems in certain adults. It is available as a liquid solution in prefilled injection pens.
RAPS

Trulicity Instagram post draws OPDP’s first untitled letter of 2022

In an untitled letter dated 19 January 2022, the US Food and Drug Administration’s (FDA) Office of Prescription Drug Promotion (OPDP) cites drugmaker Eli Lilly for a social media post about its type 2 ...
Nasdaq

Once-weekly Trulicity® (dulaglutide) demonstrates significantly higher adherence and more persistence compared to once-weekly semaglutide and exenatide injections

INDIANAPOLIS, June 13, 2020 /PRNewswire/ -- New real-world data showed Trulicity® (dulaglutide) had significantly higher adherence and longer persistence compared to weekly injections of semaglutide ...
Yahoo Finance

Lilly (LLY) Gets FDA Approval for Higher Doses of Trulicity

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Forbes

Trulicity: Approved Uses, Weight Loss and More

Carley is a writer, editor and social media professional. Before starting at Forbes Health, she wrote for Sleepopolis and interned at PBS and Nickelodeon. She's a certified sleep science coach and ...
Business Insider

Trulicity® (dulaglutide) significantly reduced major cardiovascular events for broad range of people with type 2 diabetes

INDIANAPOLIS, June 9, 2019 /PRNewswire/ -- Detailed results from REWIND, the Trulicity ® (dulaglutide) cardiovascular outcome trial, showed a significant 12 percent reduction in major cardiovascular ...
FiercePharma

ADA: Lilly's Trulicity cuts heart risks by 12%. Is it enough to fend off Novo's semaglutide?

SAN FRANCISCO—Back in November, news of a cardiovascular outcomes win for Trulicity pleased Eli Lilly investors whom analysts called “skeptical.” Now, those same skeptics may wonder just how well ...
CNN

Trulicity® (dulaglutide) is the first and only type 2 diabetes medicine approved to reduce cardiovascular events in adults with and without established cardiovascular disease

The new indication reflects the differentiated patient population of REWIND, the Trulicity cardiovascular outcomes trial. While all participants had CV risk factors, the study consisted primarily of ...
MM&M

Eli Lilly diabetes drugs Mounjaro and Trulicity in short supply, FDA says

Eli Lilly’s diabetes drugs Mounjaro and Trulicity are in short supply due to heightened demand for the medication, the Food and Drug Administration (FDA) announced recently. Pharmacies are ...
Nasdaq

Trulicity® (dulaglutide) is the first and only type 2 diabetes medicine approved to reduce cardiovascular events in adults with and without established cardiovascular disease

New indication reflects distinct patient population in the REWIND study, including primarily people with multiple cardiovascular risk factors but without established cardiovascular disease ...